• Pain Management Pharmacogenetics (PGx) Gene Variation Panel
  • TGFB3 Gene Mutation Analysis
  • Interferon B-1 (IFNB-1) Neutralizing Antibody
  • Phenobarbital, Urine
  • Dexamethasone Suppression Test (Low Dose)
  • Tubulin receptor (Tubulin) Antibody, IgG
  • Adenovirus Antibody
  • Crystal Identification, Synovial Fluid
  • HER2/neu (ERBB2) Gene Amplification, FISH, Breast Cancer
  • HLA-B27 Genotyping for Uveitis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Methodology
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.